Xtl Biopharmaceuticals Aktie
WKN DE: A2DK34 / ISIN: US98386D3070
07.04.2025 17:29:22
|
XTL Biopharmaceuticals Names Noam Band CEO
(RTTNews) - XTL Biopharmaceuticals Ltd. (XTLB) Monday announced the appointment of Noam Band as Chief Executive Officer. Band has previously served as the Chairman and CEO of Gix Internet Ltd. and as the CEO of Dotomi.
Currently, XTLB is at $1.2, up 21.21 percent .
The company said Shlomo Shalev will continue as the Chairman of the Board.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Xtl Biopharmaceuticals Ltd (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Xtl Biopharmaceuticals Ltd (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Xtl Biopharmaceuticals Ltd (spons. ADRs) | 1,01 | 8,60% |
|